DENTSPLY SIRONA Statistics
Total Valuation
XRAY has a market cap or net worth of $4.86 billion. The enterprise value is $6.82 billion.
Important Dates
The next confirmed earnings date is Thursday, November 7, 2024, before market open.
Earnings Date | Nov 7, 2024 |
Ex-Dividend Date | Sep 27, 2024 |
Share Statistics
XRAY has 202.71 million shares outstanding. The number of shares has decreased by -3.43% in one year.
Current Share Class | 202.71M |
Shares Outstanding | 202.71M |
Shares Change (YoY) | -3.43% |
Shares Change (QoQ) | -2.24% |
Owned by Insiders (%) | 0.71% |
Owned by Institutions (%) | 110.48% |
Float | 201.07M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | 10.81 |
PS Ratio | 1.27 |
Forward PS | 1.20 |
PB Ratio | 1.94 |
P/FCF Ratio | 13.32 |
PEG Ratio | 1.17 |
Financial Ratio History Enterprise Valuation
The stock's EV/EBITDA ratio is 10.89, with an EV/FCF ratio of 18.67.
EV / Earnings | n/a |
EV / Sales | 1.75 |
EV / EBITDA | 10.89 |
EV / EBIT | 24.34 |
EV / FCF | 18.67 |
Financial Position
The company has a current ratio of 1.25, with a Debt / Equity ratio of 0.93.
Current Ratio | 1.25 |
Quick Ratio | 0.63 |
Debt / Equity | 0.93 |
Debt / EBITDA | 3.27 |
Debt / FCF | 6.36 |
Interest Coverage | 3.15 |
Financial Efficiency
Return on equity (ROE) is -13.99% and return on invested capital (ROIC) is 3.38%.
Return on Equity (ROE) | -13.99% |
Return on Assets (ROA) | 2.53% |
Return on Capital (ROIC) | 3.38% |
Revenue Per Employee | $260,000 |
Profits Per Employee | -$27,533 |
Employee Count | 15,000 |
Asset Turnover | 0.56 |
Inventory Turnover | 2.93 |
Taxes
In the past 12 months, XRAY has paid $54.00 million in taxes.
Income Tax | 54.00M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -17.90% in the last 52 weeks. The beta is 1.03, so XRAY's price volatility has been similar to the market average.
Beta (5Y) | 1.03 |
52-Week Price Change | -17.90% |
50-Day Moving Average | 24.97 |
200-Day Moving Average | 28.20 |
Relative Strength Index (RSI) | 47.49 |
Average Volume (20 Days) | 2,436,864 |
Short Selling Information
The latest short interest is 16.35 million, so 8.07% of the outstanding shares have been sold short.
Short Interest | 16.35M |
Short Previous Month | 19.18M |
Short % of Shares Out | 8.07% |
Short % of Float | 8.13% |
Short Ratio (days to cover) | 7.75 |
Income Statement
In the last 12 months, XRAY had revenue of $3.90 billion and -$413.00 million in losses. Loss per share was -$2.00.
Revenue | 3.90B |
Gross Profit | 2.04B |
Operating Income | 280.00M |
Pretax Income | -132.00M |
Net Income | -413.00M |
EBITDA | 626.00M |
EBIT | 280.00M |
Loss Per Share | -$2.00 |
Full Income Statement Balance Sheet
The company has $296.00 million in cash and $2.32 billion in debt, giving a net cash position of -$2.02 billion or -$9.98 per share.
Cash & Cash Equivalents | 296.00M |
Total Debt | 2.32B |
Net Cash | -2.02B |
Net Cash Per Share | -$9.98 |
Equity (Book Value) | 2.49B |
Book Value Per Share | 12.39 |
Working Capital | 379.00M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was $534.00 million and capital expenditures -$169.00 million, giving a free cash flow of $365.00 million.
Operating Cash Flow | 534.00M |
Capital Expenditures | -169.00M |
Free Cash Flow | 365.00M |
FCF Per Share | $1.80 |
Full Cash Flow Statement Margins
Gross margin is 52.26%, with operating and profit margins of 7.18% and -10.59%.
Gross Margin | 52.26% |
Operating Margin | 7.18% |
Pretax Margin | -9.13% |
Profit Margin | -10.59% |
EBITDA Margin | 16.05% |
EBIT Margin | 7.18% |
FCF Margin | 9.52% |
Dividends & Yields
This stock pays an annual dividend of $0.64, which amounts to a dividend yield of 2.67%.
Dividend Per Share | $0.64 |
Dividend Yield | 2.67% |
Dividend Growth (YoY) | 13.76% |
Years of Dividend Growth | 5 |
Payout Ratio | n/a |
Buyback Yield | 3.43% |
Shareholder Yield | 6.10% |
Earnings Yield | -8.50% |
FCF Yield | 7.51% |
Dividend Details Analyst Forecast
The average price target for XRAY is $32.67, which is 36.24% higher than the current price. The consensus rating is "Buy".
Price Target | $32.67 |
Price Target Difference | 36.24% |
Analyst Consensus | Buy |
Analyst Count | 10 |
Revenue Growth Forecast (5Y) | 4.07% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
The last stock split was on July 18, 2006. It was a forward split with a ratio of 2:1.
Last Split Date | Jul 18, 2006 |
Split Type | Forward |
Split Ratio | 2:1 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 5 |